Allen Patricia L

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 58% 68% 82%
Transactions
6 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Allen Patricia L's trades of Zenas Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
329.88
Quantity 6,224 -43.6%
Value US$1,527,894
Transaction date
Purchase
Price
263.34
Quantity 7,996 -12.2%
Value US$4,081,041
Transaction date
Purchase
Price
412.31
Quantity 63,714 -3.1%
Value US$4,537,068
Transaction date
Purchase
Price
23.77
Quantity 5,000 +inf%
Value US$118,850
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-13 2026-02-13
B Purchase
6,224 -43.6%
329.88
US$1,527,894 		6,224 -43.6% 329.88 US$1,527,894
2026-02-13 2026-02-12
B Purchase
7,996 -12.2%
263.34
US$4,081,041 		7,996 -12.2% 263.34 US$4,081,041
2026-02-13 2026-02-12
B Purchase
63,714 -3.1%
412.31
US$4,537,068 		63,714 -3.1% 412.31 US$4,537,068
2026-02-13 2026-02-12
B Purchase
5,000 +inf%
23.77
US$118,850 		5,000 +inf% 23.77 US$118,850
2020-06-05 2020-06-05
S Sale
5,635 -100.0%
55.90
US$314,999 		5,635 -100.0% 55.90 US$314,999
2020-06-05 2020-06-03
S Sale
6,365 -100.0%
59.14
US$376,450 		6,365 -100.0% 59.14 US$376,450
2020-01-28 2020-01-24
PlS Planned sale
700 -100.0%
67.36
US$47,151 		700 -100.0% 67.36 US$47,151
2020-01-28 2020-01-24
PlS Planned sale
6,496 -90.3%
66.55
US$432,303 		6,496 -90.3% 66.55 US$432,303
2020-01-28 2020-01-24
PlS Planned sale
17,804 -71.2%
65.93
US$1,173,871 		17,804 -71.2% 65.93 US$1,173,871